PD-L1 Testing Laboratory Services

County Durham and Darlington NHS Foundation Trust (CDDFT) is seeking a qualified provider to deliver PD-L1 (Programmed Death-Ligand 1) molecular pathology diagnostic testing services. This service is critical for supporting oncology treatment decisions, as PD-L1 testing helps identify patients who may benefit from immunotherapy treatments. The provider must deliver accurate, reliable test results within defined timeframes to maintain continuity of patient care and meet NHS regulatory and quality standards. Suppliers should have accreditation in molecular pathology diagnostics, experience with PD-L1 assays, robust quality management systems, and the capacity to handle the anticipated testing volume. This is an essential clinical service that directly impacts patient treatment outcomes and pathway decisions.